Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer

被引：1
|
作者：
Lippman, Marc [1 ]
机构：
[1] Georgetown Univ, Dept Oncol, Washington, DC 20057 USA
来源：
LANCET ONCOLOGY | 2019年 / 20卷 / 03期
关键词：
D O I：
10.1016/S1470-2045(18)30913-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：312 / 313
页数：2
相关论文
共 50 条
  • [1] Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer
    Johnston, Stephen R. D.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (01) : 89 - 102
  • [2] Postmenopausal Hormone Receptor-Positive Advanced Breast Cancer
    Connolly, Roisin M.
    Stearns, Vered
    [J]. ONCOLOGY-NEW YORK, 2013, 27 (06): : 571 - +
  • [3] Adjuvant Endocrine Therapy of Perimenopausal and Recently Postmenopausal Women With Hormone Receptor-Positive Breast Cancer
    Pan, Kathy
    Chlebowski, Rowan T.
    [J]. CLINICAL BREAST CANCER, 2014, 14 (03) : 147 - 153
  • [4] Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index
    Sendur, M. A. N.
    Aksoy, S.
    Zengin, N.
    Altundag, K.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 107 (11) : 1815 - 1819
  • [5] Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index
    M A N Sendur
    S Aksoy
    N Zengin
    K Altundag
    [J]. British Journal of Cancer, 2012, 107 : 1815 - 1819
  • [6] Obesity and Postmenopausal Hormone Receptor-positive Breast Cancer: Epidemiology and Mechanisms
    Zuo, Qianying
    Band, Shoham
    Kesavadas, Mrinali
    Madak Erdogan, Zeynep
    [J]. ENDOCRINOLOGY, 2021, 162 (12)
  • [7] The effect of using adjuvant aromatase inhibitors on cognitive functions in postmenopausal women with hormone receptor-positive breast cancer
    Ilhan, Rukiye Guler
    Ilhan, Yusuf
    Goksu, Sema Sezgin
    Tatli, Ali Murat
    Coskun, Hasan Senol
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 1) : S368 - S372
  • [8] Optimal timing of the use of an aromatase inhibitor in the adjuvant treatment of postmenopausal hormone receptor-positive breast cancer.
    Cuzick, J
    Howell, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 43S - 43S
  • [9] Adjuvant therapy with aromatase inhibitors in postmenopausal, estrogen receptor-positive breast cancer patients: upfront or sequential?
    Dediu, M.
    Median, D.
    Alexandru, A.
    Vremes, G.
    Gal, C.
    Gongu, M.
    [J]. JOURNAL OF BUON, 2009, 14 (03): : 375 - 379
  • [10] Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients in the TEAM Trial
    Bartlett, John M. S.
    Xu, Keying
    Wong, Jenna
    Pond, Gregory
    Zhang, Yi
    Spears, Melanie
    Salunga, Ranelle
    Mallon, Elizabeth
    Taylor, Karen J.
    Hasenburg, Annette
    Markopoulos, Christos
    Dirix, Luc
    van de Velde, Cornelis J. H.
    Rea, Daniel
    Schnabel, Catherine A.
    Treuner, Kai
    Bayani, Jane
    [J]. CLINICAL CANCER RESEARCH, 2024, 30 (08) : 1509 - 1517
12345